Impact of radiation on host immune system in patients treated with chemoradiotherapy and durvalumab consolidation for unresectable locally advanced non-small cell lung cancer.

Frontiers in oncology(2023)

引用 5|浏览4
暂无评分
摘要
The inclusion of at least one NITDLN station within the CTV was an independent factor for poorer PFS in the context of CCRT and durvalumab for LA-NSCLC. The optimal sparing of immune structures might help in achieving better synergy between radiotherapy and immunotherapy in this indication.
更多
查看译文
关键词
radiotherapy,immunotherapy,non-small cell lung cancer (NSCLC),tumor-draining lymph nodes (TDLN),EDRIC,lymphopenia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要